Reference

1. ^Cosford ND; Tehrani L; Roppe J; et al. (2003). „3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity”.J. Med. Chem.46 (2): 204—6.PMID 12519057.doi:10.1021/jm025570j. CS1 одржавање: Експлицитна употреба et al. (веза)
2. ^Iso Y; Grajkowska E; Wroblewski JT; et al. (2006). „Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications”.J. Med. Chem.49 (3): 1080—100.PMID 16451073.doi:10.1021/jm050570f. CS1 одржавање: Експлицитна употреба et al. (веза)
3. ^Kulkarni SS, Newman AH (2007).„Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists”.Bioorg. Med. Chem. Lett.17 (11): 2987—91.PMC 1973162 .PMID 17446071.doi:10.1016/j.bmcl.2007.03.066. 

Spoljašnje veze